Mogrify
Mogrify is transforming the lives of patients with degenerative diseases through a novel class of in vivo reprogramming therapies.
Private Company
Total funding raised: $53M
About
Mogrify is transforming the lives of patients with degenerative diseases through a novel class of in vivo reprogramming therapies.
Cell & Gene Therapy
Funding History
2Total raised:$53M
Series B$37M
Series A$16M